Literature DB >> 6493347

Role of muscarinic cholinergic mechanisms in the substantia nigra pars reticulata in mediating muscular rigidity in rats.

L Turski, U Havemann, K Kuschinsky.   

Abstract

Bethanechol chloride (5-25 micrograms), when injected into the substantia nigra pars reticulata (SNR) of rats, produced muscular rigidity in a dose-dependent way, and in addition, catalepsy and ipsilateral posture. The effects of bethanechol in the dose of 25 micrograms were prevented by co-administration of 10 micrograms scopolamine hydrochloride. Injections of 25 micrograms bethanechol or 10 micrograms scopolamine into the reticulata only slightly affected the muscular rigidity produced by 15 mg/kg i.p. morphine hydrochloride. The results suggest that muscarinic cholinergic mechanisms in the substantia nigra pars reticulata, although effective by themselves, affect by expression of at least one striatal functional alteration, the muscular rigidity, in a less effective way than GABAergic or endogenous opioid mechanisms do.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6493347     DOI: 10.1007/bf00504985

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  Neurochemical aspects of the opioid-induced 'catatonia'.

Authors:  U Havemann; K Kuschinsky
Journal:  Neurochem Int       Date:  1982       Impact factor: 3.921

2.  Changes in neostriatal DA metabolism after carbachol or atropine microinjections into the substantia nigra.

Authors:  F Javoy; Y Agid; D Bouvet; J Glowinski
Journal:  Brain Res       Date:  1974-03-22       Impact factor: 3.252

Review 3.  The physiology and pharmacology of mammalian basal ganglia.

Authors:  A Dray
Journal:  Prog Neurobiol       Date:  1980       Impact factor: 11.685

4.  Evidence for a possible dopaminergic link in the action of acetylcholine in the rat substantia nigra.

Authors:  T A James; S Massey
Journal:  Neuropharmacology       Date:  1978-09       Impact factor: 5.250

5.  Evidence that opioid receptors in the substantia nigra pars reticulata are relevant in regulating the function of striatal efferent pathways.

Authors:  L Turski; U Havemann; K Kuschinsky
Journal:  Behav Brain Res       Date:  1982-08       Impact factor: 3.332

6.  Nigral GABAergic mechanisms and EMG activity in rats: differences between pars reticulata and pars compacta.

Authors:  U Havemann; L Turski; M Schwarz; K Kuschinsky
Journal:  Eur J Pharmacol       Date:  1983-08-19       Impact factor: 4.432

7.  Role of GABAergic mechanisms in the substantia nigra pars reticulata in modulating morphine-induced muscular rigidity in rats.

Authors:  U Havemann; L Turski; K Kuschinsky
Journal:  Neurosci Lett       Date:  1982-07-20       Impact factor: 3.046

8.  The role of the substantia nigra in motility of the rat. Muscular rigidity, body asymmetry and catalepsy after injection of morphine into the nigra.

Authors:  L Turski; U Havemann; K Kuschinsky
Journal:  Neuropharmacology       Date:  1983-09       Impact factor: 5.250

9.  Evidence that a nigral gabaergic--cholinergic balance controls posture.

Authors:  G M De Montis; M C Olianas; G Serra; A Tagliamonte; J Scheel-Krüger
Journal:  Eur J Pharmacol       Date:  1979-01-01       Impact factor: 4.432

10.  [3H] Quinuclidinyl benzylate and [3H] GABA receptor binding in rat substantia nigra after 6-hydroxy-dopamine lesions.

Authors:  A J Cross; J L Waddington
Journal:  Neurosci Lett       Date:  1980-05-01       Impact factor: 3.046

  10 in total
  3 in total

1.  Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease.

Authors:  Zixiu Xiang; Analisa D Thompson; Carrie K Jones; Craig W Lindsley; P Jeffrey Conn
Journal:  J Pharmacol Exp Ther       Date:  2011-12-01       Impact factor: 4.030

2.  The striatal dopaminergic catalepsy mechanism is not necessary for the expression of pontine catalepsy produced by carbachol injections into the pontine reticular formation.

Authors:  Z Elazar; N Peleg; M Paz; G Ring
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

3.  Electrophysiological actions of nicotine on substantia nigra single units.

Authors:  P B Clarke; D W Hommer; A Pert; L R Skirboll
Journal:  Br J Pharmacol       Date:  1985-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.